Catalyst Health Economics Consultants

Sleep Disorders

1. Cost-effectiveness of using continuous positive airway pressure in the treatment of severe obstructive sleep apnoea/hypopnoea syndrome in the UK

Authors: JF Guest, MT Helter, A Morga & JR Stradling
Source: Thorax 2008; 63: 860-865.

View Abstract


2. Cost-effectiveness of using continuous positive airways pressure in treating severe obstructive sleep apnoea/hypopnoea syndrome in the UK.

Presented at the 19th Congress of the European Sleep Research Society (ESRS), Glasgow, September 2008.

3. Clinical outcomes and cost-effectiveness of using positive airway pressure to manage sleep apnoea in patients with type 2 diabetes in the UK.

Presented at the European Respiratory Society Annual Congress, Barcelona, September 2013.

4. Clinical effectiveness and cost-effectiveness of using positive airways pressure to manage sleep apnoea in patients with type 2 diabetes in the UK.

Presented at the 49th European Association for the Study of Diabetes (EASD) Annual Meeting Barcelona, September 2013.

5. Clinical outcomes and cost-effectiveness of continuous positive airway pressure to manage obstructive sleep apnoea in patients with type 2 diabetes in the U.K.

Author: JF Guest, M Panca, E Sladkevicius, S Taheri, J Stradling.
Source: Diabetes Care 2014;37:1–9.

View Abstract


<<< Go Back

Catalyst Health Economics Consultants Ltd
© 1991 - 2018